The Asia Pacific IV Dressing Market would witness market growth of 6.7% CAGR during the forecast period (2024-2031). In the year 2022, the Asia Pacific market's volume surged to 11,017.4 thousand units, showcasing a growth of 18.1% (2020-2023).
Transparent IV dressings are a vital component in the market, offering a clear advantage in patient care. These dressings provide a protective barrier over intravenous insertion sites while allowing clinicians to monitor the site without removing the dressing. Their transparent nature facilitates easy inspection for signs of infection, leakage, or skin irritation, enhancing patient safety and comfort. Therefore, the China market consumed 3,090.3 thousand units of Transparent IV dressings in 2023.
The China market dominated the Asia Pacific IV Dressing Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $88.1 Million by 2031. The Japan market is registering a CAGR of 6.1% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 7.4% during (2024 - 2031).
As technology advances, this with prolonged wear periods are available, reducing the frequency of dressing changes and minimizing disturbance to patient care. This is particularly beneficial for patients receiving long-term IV therapy. The dressings are designed to accommodate various types and sizes of IV catheters, including peripheral, central, and arterial lines. They are offered in various configurations and forms to accommodate the specific needs of various clinical applications.
Manufacturers increasingly focus on designing with features that prioritize patient comfort and convenience. This includes softer materials, hypoallergenic adhesives, transparent designs for easy monitoring. With the increasing prevalence of antibiotic-resistant infections and the growing emphasis on infection prevention, there is a rising demand for this with antimicrobial properties. These dressings help to reduce the risk of catheter-related bloodstream infections (CRBSIs) and other complications.
According to a report published by the American College of Cardiology in April 2021, cardiovascular disease is Asia’s leading cause of mortality. As per Invest India, in FY17, the hospital industry in India was worth $ 61.79 billion, projected to reach $ 132 billion by 2023. India has been witnessing a rapid expansion of healthcare facilities, including hospitals, clinics, and specialty centers. The establishment of new hospitals and the expansion of existing ones, especially in urban and semi-urban areas, cater to the increasing healthcare needs of the population in India. In India, where the prevalence of infectious diseases and the likelihood of healthcare-associated infections (HAIs) are significant concerns, infection control is a crucial aspect of healthcare provision. Therefore, due to the above-mentioned factors, the market will grow significantly in this region.
Free Valuable Insights: The Global IV Dressing Market is Predict to reach USD 1.3 Billion by 2031, at a CAGR of 5.9%
Based on Type, the market is segmented into Transparent, and Translucent. Based on End-use, the market is segmented into Hospitals, Clinics, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
By Type (Volume, Thousand Units, USD Billion, 2020-2031)
By End-use (Volume, Thousand Units, USD Billion, 2020-2031)
By Country (Volume, Thousand Units, USD Billion, 2020-2031)
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 